Cargando…

Higher Magnesium Intake Reduces Risk of Impaired Glucose and Insulin Metabolism and Progression From Prediabetes to Diabetes in Middle-Aged Americans

OBJECTIVE: To assess 7-year associations between magnesium intake and incident prediabetes and/or insulin resistance (IR), and progression from these states to type 2 diabetes. RESEARCH DESIGN AND METHODS: In 2,582 community-dwelling participants 26–81 years old at baseline, magnesium intake and ris...

Descripción completa

Detalles Bibliográficos
Autores principales: Hruby, Adela, Meigs, James B., O’Donnell, Christopher J., Jacques, Paul F., McKeown, Nicola M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898748/
https://www.ncbi.nlm.nih.gov/pubmed/24089547
http://dx.doi.org/10.2337/dc13-1397
_version_ 1782300463845081088
author Hruby, Adela
Meigs, James B.
O’Donnell, Christopher J.
Jacques, Paul F.
McKeown, Nicola M.
author_facet Hruby, Adela
Meigs, James B.
O’Donnell, Christopher J.
Jacques, Paul F.
McKeown, Nicola M.
author_sort Hruby, Adela
collection PubMed
description OBJECTIVE: To assess 7-year associations between magnesium intake and incident prediabetes and/or insulin resistance (IR), and progression from these states to type 2 diabetes. RESEARCH DESIGN AND METHODS: In 2,582 community-dwelling participants 26–81 years old at baseline, magnesium intake and risk of incident “metabolic impairment,” defined as impaired fasting glucose (FG) (≥5.6 to <7.0 mmol/L), impaired glucose tolerance (2-h postload glucose ≥7.8 to <11.1 mmol/L), IR, or hyperinsulinemia (≥90th percentile of homeostasis model assessment of IR or fasting insulin, respectively), was estimated among those with normal baseline status, and risk of incident diabetes was estimated among those with baseline metabolic impairment. In participants without incident diabetes, we examined magnesium intake in relation to 7-year changes in fasting and postload glucose and insulin, IR, and insulin sensitivity. RESULTS: After adjusting for age, sex, and energy intake, compared with those with the lowest magnesium intake, those with the highest intake had 37% lower risk of incident metabolic impairment (P trend = 0.02), and in those with baseline metabolic impairment, higher intake was associated with 32% lower risk of incident diabetes (P trend = 0.05). In the combined population, the risk in those with the highest intake was 53% (P trend = 0.0004) of those with the lowest intake. Adjusting for risk factors and dietary fiber attenuated associations in the baseline normal population but did not substantially affect associations in the metabolically impaired. Higher magnesium intake tended to associate with lower follow-up FG and IR, but not fasting insulin, postload values, or insulin sensitivity. CONCLUSIONS: Magnesium intake may be particularly beneficial in offsetting risk of developing diabetes among those at high risk. Magnesium’s long-term associations with non–steady-state (dynamic) measures deserve further research.
format Online
Article
Text
id pubmed-3898748
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher American Diabetes Association
record_format MEDLINE/PubMed
spelling pubmed-38987482015-02-01 Higher Magnesium Intake Reduces Risk of Impaired Glucose and Insulin Metabolism and Progression From Prediabetes to Diabetes in Middle-Aged Americans Hruby, Adela Meigs, James B. O’Donnell, Christopher J. Jacques, Paul F. McKeown, Nicola M. Diabetes Care Epidemiology/Health Services Research OBJECTIVE: To assess 7-year associations between magnesium intake and incident prediabetes and/or insulin resistance (IR), and progression from these states to type 2 diabetes. RESEARCH DESIGN AND METHODS: In 2,582 community-dwelling participants 26–81 years old at baseline, magnesium intake and risk of incident “metabolic impairment,” defined as impaired fasting glucose (FG) (≥5.6 to <7.0 mmol/L), impaired glucose tolerance (2-h postload glucose ≥7.8 to <11.1 mmol/L), IR, or hyperinsulinemia (≥90th percentile of homeostasis model assessment of IR or fasting insulin, respectively), was estimated among those with normal baseline status, and risk of incident diabetes was estimated among those with baseline metabolic impairment. In participants without incident diabetes, we examined magnesium intake in relation to 7-year changes in fasting and postload glucose and insulin, IR, and insulin sensitivity. RESULTS: After adjusting for age, sex, and energy intake, compared with those with the lowest magnesium intake, those with the highest intake had 37% lower risk of incident metabolic impairment (P trend = 0.02), and in those with baseline metabolic impairment, higher intake was associated with 32% lower risk of incident diabetes (P trend = 0.05). In the combined population, the risk in those with the highest intake was 53% (P trend = 0.0004) of those with the lowest intake. Adjusting for risk factors and dietary fiber attenuated associations in the baseline normal population but did not substantially affect associations in the metabolically impaired. Higher magnesium intake tended to associate with lower follow-up FG and IR, but not fasting insulin, postload values, or insulin sensitivity. CONCLUSIONS: Magnesium intake may be particularly beneficial in offsetting risk of developing diabetes among those at high risk. Magnesium’s long-term associations with non–steady-state (dynamic) measures deserve further research. American Diabetes Association 2014-02 2014-01-11 /pmc/articles/PMC3898748/ /pubmed/24089547 http://dx.doi.org/10.2337/dc13-1397 Text en © 2014 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.
spellingShingle Epidemiology/Health Services Research
Hruby, Adela
Meigs, James B.
O’Donnell, Christopher J.
Jacques, Paul F.
McKeown, Nicola M.
Higher Magnesium Intake Reduces Risk of Impaired Glucose and Insulin Metabolism and Progression From Prediabetes to Diabetes in Middle-Aged Americans
title Higher Magnesium Intake Reduces Risk of Impaired Glucose and Insulin Metabolism and Progression From Prediabetes to Diabetes in Middle-Aged Americans
title_full Higher Magnesium Intake Reduces Risk of Impaired Glucose and Insulin Metabolism and Progression From Prediabetes to Diabetes in Middle-Aged Americans
title_fullStr Higher Magnesium Intake Reduces Risk of Impaired Glucose and Insulin Metabolism and Progression From Prediabetes to Diabetes in Middle-Aged Americans
title_full_unstemmed Higher Magnesium Intake Reduces Risk of Impaired Glucose and Insulin Metabolism and Progression From Prediabetes to Diabetes in Middle-Aged Americans
title_short Higher Magnesium Intake Reduces Risk of Impaired Glucose and Insulin Metabolism and Progression From Prediabetes to Diabetes in Middle-Aged Americans
title_sort higher magnesium intake reduces risk of impaired glucose and insulin metabolism and progression from prediabetes to diabetes in middle-aged americans
topic Epidemiology/Health Services Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898748/
https://www.ncbi.nlm.nih.gov/pubmed/24089547
http://dx.doi.org/10.2337/dc13-1397
work_keys_str_mv AT hrubyadela highermagnesiumintakereducesriskofimpairedglucoseandinsulinmetabolismandprogressionfromprediabetestodiabetesinmiddleagedamericans
AT meigsjamesb highermagnesiumintakereducesriskofimpairedglucoseandinsulinmetabolismandprogressionfromprediabetestodiabetesinmiddleagedamericans
AT odonnellchristopherj highermagnesiumintakereducesriskofimpairedglucoseandinsulinmetabolismandprogressionfromprediabetestodiabetesinmiddleagedamericans
AT jacquespaulf highermagnesiumintakereducesriskofimpairedglucoseandinsulinmetabolismandprogressionfromprediabetestodiabetesinmiddleagedamericans
AT mckeownnicolam highermagnesiumintakereducesriskofimpairedglucoseandinsulinmetabolismandprogressionfromprediabetestodiabetesinmiddleagedamericans